AEON Biopharma Inc.

NASDAQ: AEON · Real-Time Price · USD
0.80
0.02 (2.56%)
At close: Aug 15, 2025, 3:59 PM
0.80
-0.62%
After-hours: Aug 15, 2025, 07:50 PM EDT

AEON Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
42.01M -52.56M -55.64M
Depreciation & Amortization
97K 68K 3K
Stock-Based Compensation
6.25M 5.89M 5.22M
Other Working Capital
-1.82M -345K 2.31M
Other Non-Cash Items
-69.35M -3K 19.38M
Deferred Income Tax
n/a 4.75M 1.18M
Change in Working Capital
706K 6.27M 1.42M
Operating Cash Flow
-20.29M -35.58M -28.43M
Capital Expenditures
n/a -306K -170K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
n/a -306K -170K
Debt Repayment
15M 40.51M 15M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a n/a -1.44M
Financial Cash Flow
15.15M 40.51M 13.56M
Net Cash Flow
-5.14M 4.62M -15.04M
Free Cash Flow
-20.29M -35.89M -28.6M